4//SEC Filing
Adkins William 4
Accession 0001493152-23-000319
CIK 0001757499other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:10 PM ET
Size
8.5 KB
Accession
0001493152-23-000319
Insider Transaction Report
Form 4
Adkins William
Director
Transactions
- Sale
COMMON STOCK
2022-12-29$1.60/sh−995$1,597→ 184,071 total - Other
WARRANTS (right to buy)
2022-09-02+138,889→ 138,889 totalExercise: $4.00From: 2022-09-02Exp: 2025-09-02→ Common Stock (138,889 underlying)
Footnotes (3)
- [F1]Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
- [F2]Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust").
- [F3]Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering.
Documents
Issuer
Shuttle Pharmaceuticals Holdings, Inc.
CIK 0001757499
Entity typeother
Related Parties
1- filerCIK 0001945434
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:10 PM ET
- Size
- 8.5 KB